Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 14356 | 23.29 |
09:34 ET | 78715 | 22.985 |
09:36 ET | 10574 | 22.9 |
09:38 ET | 11144 | 22.895 |
09:39 ET | 8220 | 22.936 |
09:41 ET | 3295 | 22.865 |
09:43 ET | 13356 | 22.9 |
09:45 ET | 999 | 22.88 |
09:48 ET | 23661 | 23.01 |
09:50 ET | 70179 | 22.985 |
09:52 ET | 14663 | 23.05 |
09:54 ET | 6573 | 23.02 |
09:56 ET | 2381 | 23.005 |
09:57 ET | 8721 | 23.04 |
09:59 ET | 1813 | 23.07 |
10:01 ET | 9415 | 23.21 |
10:03 ET | 6719 | 23.1 |
10:06 ET | 12330 | 23.13 |
10:08 ET | 6520 | 22.94 |
10:10 ET | 2668 | 22.92 |
10:12 ET | 6834 | 22.85 |
10:14 ET | 10402 | 22.815 |
10:15 ET | 20354 | 22.83 |
10:17 ET | 14187 | 22.82 |
10:19 ET | 87252 | 22.78 |
10:21 ET | 9876 | 22.82 |
10:24 ET | 3841 | 22.7653 |
10:26 ET | 2931 | 22.79 |
10:28 ET | 9270 | 22.78 |
10:30 ET | 5296 | 22.765 |
10:32 ET | 5294 | 22.75 |
10:33 ET | 13915 | 22.82 |
10:35 ET | 90634 | 22.82 |
10:37 ET | 2810 | 22.84 |
10:39 ET | 6111 | 22.84 |
10:42 ET | 19217 | 22.65 |
10:44 ET | 11480 | 22.65 |
10:46 ET | 4846 | 22.69 |
10:48 ET | 7527 | 22.66 |
10:50 ET | 6740 | 22.59 |
10:51 ET | 28193 | 22.54 |
10:53 ET | 4630 | 22.5747 |
10:55 ET | 20539 | 22.58 |
10:57 ET | 7248 | 22.58 |
11:00 ET | 6477 | 22.63 |
11:02 ET | 6724 | 22.558 |
11:04 ET | 5162 | 22.58 |
11:06 ET | 27405 | 22.475 |
11:08 ET | 10625 | 22.45 |
11:09 ET | 23207 | 22.36 |
11:11 ET | 13562 | 22.42 |
11:13 ET | 8383 | 22.4499 |
11:15 ET | 7392 | 22.465 |
11:18 ET | 4259 | 22.36 |
11:20 ET | 1720 | 22.36 |
11:22 ET | 3350 | 22.385 |
11:24 ET | 8259 | 22.4061 |
11:26 ET | 12474 | 22.325 |
11:27 ET | 9330 | 22.34 |
11:29 ET | 5068 | 22.37 |
11:31 ET | 5540 | 22.38 |
11:33 ET | 52505 | 22.38 |
11:36 ET | 46445 | 22.24 |
11:38 ET | 6644 | 22.215 |
11:40 ET | 6188 | 22.21 |
11:42 ET | 3392 | 22.23 |
11:44 ET | 4355 | 22.29 |
11:45 ET | 5527 | 22.275 |
11:47 ET | 8676 | 22.25 |
11:49 ET | 10837 | 22.26 |
11:51 ET | 5960 | 22.285 |
11:54 ET | 14824 | 22.28 |
11:56 ET | 3915 | 22.26 |
11:58 ET | 5066 | 22.2601 |
12:00 ET | 10449 | 22.32 |
12:02 ET | 4748 | 22.305 |
12:03 ET | 1713 | 22.31 |
12:05 ET | 13967 | 22.29 |
12:07 ET | 14604 | 22.23 |
12:09 ET | 3442 | 22.245 |
12:12 ET | 14187 | 22.28 |
12:14 ET | 18930 | 22.24 |
12:16 ET | 64193 | 22.245 |
12:18 ET | 14669 | 22.265 |
12:20 ET | 7654 | 22.21 |
12:21 ET | 5991 | 22.16 |
12:23 ET | 22658 | 22.19 |
12:25 ET | 11037 | 22.18 |
12:27 ET | 5566 | 22.18 |
12:30 ET | 5200 | 22.21 |
12:32 ET | 55261 | 22.26 |
12:34 ET | 9404 | 22.14 |
12:36 ET | 30079 | 22.26 |
12:38 ET | 7272 | 22.34 |
12:39 ET | 13240 | 22.31 |
12:41 ET | 3512 | 22.24 |
12:43 ET | 4506 | 22.255 |
12:45 ET | 3150 | 22.1909 |
12:48 ET | 3986 | 22.18 |
12:50 ET | 3542 | 22.21 |
12:52 ET | 9175 | 22.23 |
12:54 ET | 5053 | 22.31 |
12:56 ET | 85001 | 22.32 |
12:57 ET | 8688 | 22.4299 |
12:59 ET | 14960 | 22.49 |
01:01 ET | 15669 | 22.51 |
01:03 ET | 18541 | 22.52 |
01:06 ET | 15085 | 22.52 |
01:08 ET | 9446 | 22.52 |
01:10 ET | 48910 | 22.499 |
01:12 ET | 7812 | 22.4416 |
01:14 ET | 4178 | 22.51 |
01:15 ET | 1617 | 22.42 |
01:17 ET | 2366 | 22.41 |
01:19 ET | 4533 | 22.41 |
01:21 ET | 10121 | 22.48 |
01:24 ET | 5904 | 22.45 |
01:26 ET | 971 | 22.41 |
01:28 ET | 1906 | 22.43 |
01:30 ET | 1573 | 22.42 |
01:32 ET | 300 | 22.42 |
01:33 ET | 3509 | 22.53 |
01:35 ET | 5096 | 22.56 |
01:37 ET | 10214 | 22.51 |
01:39 ET | 5709 | 22.54 |
01:42 ET | 2861 | 22.5 |
01:44 ET | 1846 | 22.48 |
01:46 ET | 700 | 22.5 |
01:48 ET | 2426 | 22.495 |
01:50 ET | 4400 | 22.53 |
01:51 ET | 3780 | 22.54 |
01:53 ET | 2966 | 22.58 |
01:55 ET | 3352 | 22.56 |
01:57 ET | 816 | 22.6 |
02:00 ET | 7642 | 22.59 |
02:02 ET | 14853 | 22.67 |
02:04 ET | 16788 | 22.7293 |
02:06 ET | 5163 | 22.75 |
02:08 ET | 6589 | 22.72 |
02:09 ET | 66182 | 22.7 |
02:11 ET | 7878 | 22.76 |
02:13 ET | 10947 | 22.78 |
02:15 ET | 5531 | 22.79 |
02:18 ET | 1342 | 22.795 |
02:20 ET | 1905 | 22.74 |
02:22 ET | 4291 | 22.745 |
02:24 ET | 434 | 22.77 |
02:26 ET | 5252 | 22.766 |
02:27 ET | 3660 | 22.82 |
02:29 ET | 4700 | 22.8451 |
02:31 ET | 2019 | 22.8905 |
02:33 ET | 5287 | 22.93 |
02:36 ET | 26702 | 22.9 |
02:38 ET | 5121 | 22.92 |
02:40 ET | 8012 | 22.88 |
02:42 ET | 4147 | 22.885 |
02:44 ET | 5300 | 22.88 |
02:45 ET | 35090 | 23.08 |
02:47 ET | 23878 | 23.12 |
02:49 ET | 23475 | 23.14 |
02:51 ET | 4931 | 23.15 |
02:54 ET | 5881 | 23.12 |
02:56 ET | 4944 | 23.14 |
02:58 ET | 7356 | 23.12 |
03:00 ET | 11585 | 23.08 |
03:02 ET | 5962 | 23.0799 |
03:03 ET | 2394 | 23.09 |
03:05 ET | 7627 | 23.11 |
03:07 ET | 4483 | 23.07 |
03:09 ET | 2811 | 23.09 |
03:12 ET | 300 | 23.1 |
03:14 ET | 4461 | 23.12 |
03:16 ET | 20803 | 23.17 |
03:18 ET | 9509 | 23.14 |
03:20 ET | 34882 | 23.13 |
03:21 ET | 3982 | 23.08 |
03:23 ET | 5483 | 23.06 |
03:25 ET | 1985 | 23.06 |
03:27 ET | 3182 | 23.03 |
03:30 ET | 7334 | 23.04 |
03:32 ET | 4157 | 23 |
03:34 ET | 2060 | 23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 3.6B | 38.3x | --- |
Axsome Therapeutics Inc | 4.3B | -13.8x | --- |
Alvotech SA | 3.6B | -4.5x | --- |
Twist Bioscience Corp | 2.6B | -11.3x | --- |
Apellis Pharmaceuticals Inc | 3.5B | -10.1x | --- |
Denali Therapeutics Inc | 4.2B | -10.0x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.6B |
---|---|
Revenue (TTM) | $346.7M |
Shares Outstanding | 154.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.21 |
EPS | $0.60 |
Book Value | $1.06 |
P/E Ratio | 38.3x |
Price/Sales (TTM) | 10.4 |
Price/Cash Flow (TTM) | 37.8x |
Operating Margin | 29.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.